(Q50567971)

15 March 2018

title

Cost implications of routine mammography screening of women 50-69 years in the county of Funen, Denmark. (English)

1 reference

15 March 2018

0 references

1 reference

1

1 reference

15 March 2018

author name string

Gyrd-Hansen D

series ordinal

2

1 reference

15 March 2018

publication date

1 November 2000

1 reference

15 March 2018

published in

Health Policy

1 reference

15 March 2018

volume

54

1 reference

15 March 2018

issue

2

1 reference

15 March 2018

page(s)

125-141

1 reference

15 March 2018

A cost utility analysis of mammography screening in Australia.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900104-4

7 January 2021

The cost-effectiveness of breast cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900104-4

7 January 2021

Economic foundations of cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900104-4

7 January 2021

Accounting for future costs in medical cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900104-4

7 January 2021

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900104-4

7 January 2021

The cost-effectiveness of nationwide breast carcinoma screening in Finland, 1987-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900104-4

7 January 2021

The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900104-4

7 January 2021

Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900104-4

7 January 2021

Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900104-4

7 January 2021

Costs of home care for advanced breast and cervical cancer in relation to cost-effectiveness of screening

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900104-4

7 January 2021

A cost-effectiveness analysis of cervical cancer screening: health policy implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2800%2900104-4

7 January 2021

10.1016/S0168-8510(00)00104-4

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018